Spatial Genomics and Transcriptomics Market Size and Outlook 2031

Report Description

Forecast Period	2027-2031
Market Size (2025)	USD 1.03 Billion
CAGR (2026-2031)	12.78%
Fastest Growing Segment	Software
Largest Market	North America
Market Size (2031)	USD 2.12 Billion

Market Overview

The Global Spatial Genomics and Transcriptomics Market is projected to grow from USD 1.03 Billion in 2025 to USD 2.12 Billion by 2031 at a 12.78% CAGR. The Global Spatial Genomics and Transcriptomics Market encompasses advanced technologies for molecular profiling of biological samples while preserving their native spatial organization, providing critical insights into cellular function within intact tissues. Key drivers supporting market expansion include the increasing prevalence of chronic and complex diseases, a growing demand for precision medicine approaches, and ongoing advancements in fundamental biological research techniques. These factors collectively stimulate the adoption of sophisticated tools capable of unraveling intricate biological processes at a spatial resolution.

According to the American Society of Human Genetics' 2024-2025 Annual Report, journal submissions within the broader human genetics and genomics field increased by approximately 50%, reflecting significant activity and advancements in foundational research relevant to this market. However, a significant challenge impeding market growth is the substantial initial capital investment required for spatial genomics and transcriptomics instruments and associated reagents, which may limit wider accessibility and adoption, particularly for smaller research institutions.

Key Market Drivers

Advancements in spatial technologies serve as a primary catalyst for the Global Spatial Genomics and Transcriptomics Market, enhancing the precision and scope of molecular analysis within intact tissues. Innovations are continuously pushing the boundaries of resolution and data capture, enabling a more comprehensive understanding of complex biological systems. For instance, Illumina, Inc., announced in February 2025 a new spatial technology program delivering a capture area nine times larger and four times greater resolution than existing technologies, designed to map complex tissues at an expanded scale. Such technological progress allows researchers to uncover intricate cellular interactions and disease mechanisms with greater fidelity, directly influencing drug discovery and personalized medicine applications by providing richer contextual data.

Another significant driver is the increased R&D investments and funding directed towards spatial genomics and transcriptomics. These investments fuel the development of novel instruments, reagents, and analytical software, thereby expanding market capabilities and accessibility. According to a Vizgen, Inc. press release, in January 2026, the company announced the closing of a $48 million financing round led by ARCH Venture Partners to scale its platform and global presence. This financial backing facilitates critical research and commercialization efforts. Furthermore, the burgeoning scientific output in this field, with more than 100 new high-impact peer-reviewed articles leveraging Vizgen’s MERSCOPE platform having been published since late 2024, reflects a growing adoption and validation of spatial biology techniques within the broader research community.

Download Free Sample Report

Key Market Challenges

A significant challenge impeding the growth of the Global Spatial Genomics and Transcriptomics Market is the substantial initial capital investment required for specialized instruments and associated reagents. This high entry cost directly limits wider accessibility and adoption, particularly for smaller research institutions and emerging entities operating with constrained budgets. Such financial barriers slow the expansion of research capabilities and the pace of innovation, as acquiring the necessary advanced equipment becomes prohibitive.

The challenging financial landscape impacting the broader biotechnology sector further exacerbates this issue. According to the BioIndustry Association's "UK Biotech Financing 2025" report, venture capital investment in the UK biotech sector experienced a 13.2% decrease in 2025 compared to the previous year. This reduction in available capital makes it more difficult for organizations to secure the significant funding needed for costly spatial genomics and transcriptomics platforms, directly hampering market penetration and the integration of these powerful technologies into a broader range of research and development workflows.

Key Market Trends

The complex and high-dimensional data generated by spatial genomics and transcriptomics platforms are increasingly leveraged through artificial intelligence and machine learning for enhanced interpretation. These advanced computational approaches enable researchers to rapidly analyze vast datasets, identify intricate cellular patterns, and extract deeper biological insights, critical for accelerating discovery and understanding disease mechanisms. This trend is evidenced by a significant shift in resource allocation, as, according to the 2026 Biotech AI Report from Benchling, released in February 2026, 80 percent of organizations plan to increase their AI budgets in the next 12 months, channeling this capital into data infrastructure and expanded scientific modeling. This integration is essential for translating raw spatial data into actionable knowledge, influencing drug discovery and precision medicine.

Another significant trend involves the gradual transition of spatial genomics and transcriptomics from purely research-oriented tools to clinical-grade profiling applications. This shift aims to establish standardized and validated workflows for diagnostic use, patient stratification, and the development of targeted therapies. The market is influenced by the demand for precise molecular insights within intact tissue for clinical decision-making, extending beyond academic laboratories. Supporting this progression, BMKGENE announced in April 2026 the launch of its 2026 Spatial Transcriptomics Excellence Award, committing €150,000 to support 22 complimentary spatial transcriptomics service opportunities for translational projects. Such initiatives foster the necessary validation and accessibility for these technologies to be adopted in clinical and translational research settings, accelerating their impact on patient care.

Segmental Insights

The Software segment is experiencing rapid growth within the Global Spatial Genomics and Transcriptomics Market, driven by the increasing complexity and volume of data generated from spatial analyses. This segment's expansion is fundamentally linked to the critical need for sophisticated computational tools that can efficiently process, analyze, and visualize intricate spatial transcriptomics datasets. The integration of advanced algorithms, including those powered by artificial intelligence and machine learning, enables researchers to extract meaningful insights, identify complex patterns, and accurately interpret gene expression in tissue contexts. Furthermore, the demand for scalable cloud-based platforms facilitating data management and collaborative high-throughput workflows underscores the pivotal role of software in advancing spatial biology research and its applications.

Regional Insights

North America leads the Global Spatial Genomics and Transcriptomics Market, primarily driven by its robust life sciences ecosystem. The region benefits from a high concentration of well-established biotechnology and pharmaceutical companies that are pivotal in adopting these advanced technologies for drug discovery and development. Moreover, extensive research infrastructure and substantial funding, including significant support from institutions like the National Institutes of Health, consistently propel advancements in genomic research and development. This environment, coupled with a strong emphasis on personalized medicine and the early adoption of innovative diagnostic methods, solidifies North America's dominant position, particularly in addressing complex disease research.

Recent Developments

In April 2026, Quanterix Corporation introduced its Content Innovation Engine at a major industry meeting, building on the integration of Akoya Biosciences' spatial biology platform with Quanterix's ultra-sensitive immunoassay development. This innovation provided researchers with a systematic, biology-first methodology for extracting more information from tissue sections. Additionally, Quanterix debuted the PhenoCode Molecular Barcoding Kit, featuring new chemistry to enable researchers to barcode virtually any antibody for spatial applications. Early access to this kit was scheduled to begin in May 2026, further enhancing capabilities within the spatial genomics and transcriptomics field.
In March 2026, Bioptimus launched its Spatial Tissue Embedding Learning Atlas (STELA), a multinational spatial data generation initiative, in partnership with 10x Genomics and Broad Clinical Labs. The STELA project began with 10x Genomics' Xenium spatial transcriptomics platform as its foundation, designed to integrate additional spatial and molecular profiling technologies. This ambitious undertaking aimed to profile up to 100,000 patient tissue specimens across North America, Europe, and Asia. The goal was to establish the world's largest clinically linked, spatially profiled, and multimodal patient data atlas, significantly expanding resources for the global spatial genomics and transcriptomics market.
In October 2025, Greenstone Biosciences and Illumina announced a collaboration to advance precision drug discovery by integrating Greenstone's induced pluripotent stem cell (iPSC) biobank with Illumina's single-cell and spatial genomics technologies. This initiative aimed to create high-resolution molecular maps, providing detailed insights into disease biology and therapeutic responses. By combining disease-specific iPSC lines with advanced sequencing platforms, the partnership sought a deeper understanding of cellular heterogeneity and gene regulatory networks in complex disorders. The expected outcome was to accelerate target discovery, drug validation, and translational research across multiple therapeutic areas within the spatial genomics and transcriptomics market.
In August 2025, researchers at the Salk Institute achieved a significant scientific breakthrough by establishing the first genetic atlas that spans the entire life cycle of the model plant Arabidopsis. This pioneering work utilized detailed single-cell and spatial transcriptomics to capture the gene expression patterns of 400,000 cells across various developmental stages, from seed to mature plant. The publicly available resource was expected to provide crucial information for future studies on plant cell types, developmental stages, and responses to environmental stimuli. This advancement in spatial transcriptomics research offers new tools for plant biotechnology, agriculture, and environmental sciences.

Key Market Players

10X Genomics Inc.
Akoya Bioscience Ltd.
Biospyder Technologies Inc.
BioTechne Corporation
Dovetail Genomics LLC
Fluidigm Corporation
Genomic Vision SA
Illumina Inc.
Lunaphore Technologies SA
Nanostring Technolgies Inc.

By Technique	By Product Type	By Application	By End User	By Region
Spatial Transcriptomics Spatial Genomics Analysis	Instruments Consumables Software	Translational Research Drug discovery & development	Pharmaceutical & Biotechnology companies Contract Research Organizations Academic & Research Institutes	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Spatial Genomics and Transcriptomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Spatial Genomics and Transcriptomics Market, By Technique:

Spatial Transcriptomics
Spatial Genomics Analysis

Spatial Genomics and Transcriptomics Market, By Product Type:

Instruments
Consumables
Software

Spatial Genomics and Transcriptomics Market, By Application:

Translational Research
Drug discovery & development

Spatial Genomics and Transcriptomics Market, By End User:

Pharmaceutical & Biotechnology companies
Contract Research Organizations
Academic & Research Institutes

Spatial Genomics and Transcriptomics Market, By Region:

North America

United States
Canada
Mexico

Europe

France
United Kingdom
Italy
Germany
Spain

Asia Pacific

China
India
Japan
Australia
South Korea

South America

Brazil
Argentina
Colombia

Middle East & Africa

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Spatial Genomics and Transcriptomics Market.

Available Customizations:

Global Spatial Genomics and Transcriptomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Spatial Genomics and Transcriptomics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Spatial Genomics and Transcriptomics Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Technique (Spatial Transcriptomics, Spatial Genomics Analysis)

5.2.2. By Product Type (Instruments, Consumables, Software)

5.2.3. By Application (Translational Research, Drug discovery & development)

5.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)

5.2.5. By Region

5.2.6. By Company (2025)

5.3. Market Map

6. North America Spatial Genomics and Transcriptomics Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Technique

6.2.2. By Product Type

6.2.3. By Application

6.2.4. By End User

6.2.5. By Country

6.3. North America: Country Analysis

6.3.1. United States Spatial Genomics and Transcriptomics Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Technique

6.3.1.2.2. By Product Type

6.3.1.2.3. By Application

6.3.1.2.4. By End User

6.3.2. Canada Spatial Genomics and Transcriptomics Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Technique

6.3.2.2.2. By Product Type

6.3.2.2.3. By Application

6.3.2.2.4. By End User

6.3.3. Mexico Spatial Genomics and Transcriptomics Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Technique

6.3.3.2.2. By Product Type

6.3.3.2.3. By Application

6.3.3.2.4. By End User

7. Europe Spatial Genomics and Transcriptomics Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Technique

7.2.2. By Product Type

7.2.3. By Application

7.2.4. By End User

7.2.5. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Spatial Genomics and Transcriptomics Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Technique

7.3.1.2.2. By Product Type

7.3.1.2.3. By Application

7.3.1.2.4. By End User

7.3.2. France Spatial Genomics and Transcriptomics Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Technique

7.3.2.2.2. By Product Type

7.3.2.2.3. By Application

7.3.2.2.4. By End User

7.3.3. United Kingdom Spatial Genomics and Transcriptomics Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Technique

7.3.3.2.2. By Product Type

7.3.3.2.3. By Application

7.3.3.2.4. By End User

7.3.4. Italy Spatial Genomics and Transcriptomics Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Technique

7.3.4.2.2. By Product Type

7.3.4.2.3. By Application

7.3.4.2.4. By End User

7.3.5. Spain Spatial Genomics and Transcriptomics Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Technique

7.3.5.2.2. By Product Type

7.3.5.2.3. By Application

7.3.5.2.4. By End User

8. Asia Pacific Spatial Genomics and Transcriptomics Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Technique

8.2.2. By Product Type

8.2.3. By Application

8.2.4. By End User

8.2.5. By Country

8.3. Asia Pacific: Country Analysis

8.3.1. China Spatial Genomics and Transcriptomics Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Technique

8.3.1.2.2. By Product Type

8.3.1.2.3. By Application

8.3.1.2.4. By End User

8.3.2. India Spatial Genomics and Transcriptomics Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Technique

8.3.2.2.2. By Product Type

8.3.2.2.3. By Application

8.3.2.2.4. By End User

8.3.3. Japan Spatial Genomics and Transcriptomics Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Technique

8.3.3.2.2. By Product Type

8.3.3.2.3. By Application

8.3.3.2.4. By End User

8.3.4. South Korea Spatial Genomics and Transcriptomics Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Technique

8.3.4.2.2. By Product Type

8.3.4.2.3. By Application

8.3.4.2.4. By End User

8.3.5. Australia Spatial Genomics and Transcriptomics Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Technique

8.3.5.2.2. By Product Type

8.3.5.2.3. By Application

8.3.5.2.4. By End User

9. Middle East & Africa Spatial Genomics and Transcriptomics Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Technique

9.2.2. By Product Type

9.2.3. By Application

9.2.4. By End User

9.2.5. By Country

9.3. Middle East & Africa: Country Analysis

9.3.1. Saudi Arabia Spatial Genomics and Transcriptomics Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Technique

9.3.1.2.2. By Product Type

9.3.1.2.3. By Application

9.3.1.2.4. By End User

9.3.2. UAE Spatial Genomics and Transcriptomics Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Technique

9.3.2.2.2. By Product Type

9.3.2.2.3. By Application

9.3.2.2.4. By End User

9.3.3. South Africa Spatial Genomics and Transcriptomics Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Technique

9.3.3.2.2. By Product Type

9.3.3.2.3. By Application

9.3.3.2.4. By End User

10. South America Spatial Genomics and Transcriptomics Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Technique

10.2.2. By Product Type

10.2.3. By Application

10.2.4. By End User

10.2.5. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Spatial Genomics and Transcriptomics Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Technique

10.3.1.2.2. By Product Type

10.3.1.2.3. By Application

10.3.1.2.4. By End User

10.3.2. Colombia Spatial Genomics and Transcriptomics Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Technique

10.3.2.2.2. By Product Type

10.3.2.2.3. By Application

10.3.2.2.4. By End User

10.3.3. Argentina Spatial Genomics and Transcriptomics Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Technique

10.3.3.2.2. By Product Type

10.3.3.2.3. By Application

10.3.3.2.4. By End User

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)

12.2. Product Launches (If Any)

12.3. Recent Developments

13. Global Spatial Genomics and Transcriptomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. 10X Genomics Inc.

15.1.1. Business Overview

15.1.2. Products & Services

15.1.3. Recent Developments

15.1.4. Key Personnel

15.1.5. SWOT Analysis

15.2. Akoya Bioscience Ltd.

15.3. Biospyder Technologies Inc.

15.4. BioTechne Corporation

15.5. Dovetail Genomics LLC

15.6. Fluidigm Corporation

15.7. Genomic Vision SA

15.8. Illumina Inc.

15.9. Lunaphore Technologies SA

15.10. Nanostring Technolgies Inc.

16. Strategic Recommendations

17. About Us & Disclaimer

Report Description

Table of content

Figures and Tables

Frequently asked questions

What was the market size of the Global Spatial Genomics and Transcriptomics Market in 2025?

Which is the dominating region in the Global Spatial Genomics and Transcriptomics Market?

Which is the fastest growing segment in the Global Spatial Genomics and Transcriptomics Market?

What is the expected growth rate of the Global Spatial Genomics and Transcriptomics Market?